Search details
1.
Mechanisms and therapeutic implications of hypermutation in gliomas.
Nature
; 580(7804): 517-523, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32322066
2.
Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor Types.
Radiology
; 310(2): e230777, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38349246
3.
Pediatric-type low-grade gliomas in adolescents and young adults-challenges and emerging paradigms.
Childs Nerv Syst
; 2024 May 18.
Article
in English
| MEDLINE | ID: mdl-38761264
4.
Dose-dependent efficacy of bevacizumab in recurrent glioblastoma.
J Neurooncol
; 161(3): 633-641, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36749445
5.
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
J Neurooncol
; 163(3): 541-551, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37256526
6.
Brain Tumors in Adolescents and Young Adults: A Review.
Semin Neurol
; 43(6): 909-928, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37949116
7.
Current state of therapeutic focused ultrasound applications in neuro-oncology.
J Neurooncol
; 156(1): 49-59, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34661791
8.
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.
J Neurooncol
; 152(3): 515-522, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33646525
9.
Myelopathies from Neoplasms.
Semin Neurol
; 41(3): 291-302, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34030192
10.
Correction to: Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
J Neurooncol
; 163(3): 553, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37378836
11.
Bevacizumab in Recurrent High-Grade Gliomas: A Canadian Retrospective Study.
Can J Neurol Sci
; 45(1): 56-61, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29151389
12.
Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
Can J Neurol Sci
; 44(3): 288-294, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28488951
13.
MEK Inhibition in a Pilocytic Astrocytoma With a Rare KRAS Q61R Mutation in a Young Adult Patient: A Case Report.
JCO Precis Oncol
; 8: e2400174, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38905571
14.
Dose-Escalated Radiation Therapy Is Associated With Improved Outcomes for High-Grade Meningioma.
Int J Radiat Oncol Biol Phys
; 118(3): 662-671, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-37793575
15.
Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on Survival.
Int J Radiat Oncol Biol Phys
; 2024 Mar 30.
Article
in English
| MEDLINE | ID: mdl-38561051
16.
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
Clin Cancer Res
; 30(7): 1327-1337, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38252427
17.
Unique molecular, clinical, and treatment aspects of gliomas in adolescents and young adults: a review.
J Neurosurg
; 139(6): 1619-1627, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37243561
18.
Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression.
Neurooncol Adv
; 5(1): vdad083, 2023.
Article
in English
| MEDLINE | ID: mdl-37554224
19.
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.
J Clin Oncol
; 41(17): 3160-3171, 2023 06 10.
Article
in English
| MEDLINE | ID: mdl-37027809
20.
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.
Neuro Oncol
; 25(1): 199-210, 2023 01 05.
Article
in English
| MEDLINE | ID: mdl-35604410